- Filed
- Feb 14, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q3 2025 · Feb 14, 2025 | 10.08M sh |
| Shares Diluted | Q3 2025 · Dec 31, 2024 | 10.68M sh |
| Shares Diluted | Q3 2025 · Dec 31, 2024 | 10.52M sh |
| Shares Diluted | Q3 2025 · Dec 31, 2023 | 9.95M sh |
| Shares Diluted | Q3 2025 · Dec 31, 2023 | 9.51M sh |
| Capex | Q3 2025 · Dec 31, 2024 | $705K |
| Capex restated | Q3 2025 · Dec 31, 2023 | $628K |
| Operating Cash Flow | Q3 2025 · Dec 31, 2024 | $1.63M |
| Operating Cash Flow restated | Q3 2025 · Dec 31, 2023 | $1.23M |
| Stockholders Equity | Q3 2025 · Dec 31, 2024 | $6.67M |
| Stockholders Equity | Q3 2025 · Mar 31, 2024 | $7.24M |
| Current Liabilities | Q3 2025 · Dec 31, 2024 | $8.57M |
| Current Liabilities | Q3 2025 · Mar 31, 2024 | $9.45M |
| Total Liabilities | Q3 2025 · Dec 31, 2024 | $17.96M |
| Total Liabilities | Q3 2025 · Mar 31, 2024 | $18.69M |
| Current Assets | Q3 2025 · Dec 31, 2024 | $22.1M |
| Current Assets | Q3 2025 · Mar 31, 2024 | $23.54M |
| Total Assets | Q3 2025 · Dec 31, 2024 | $26.22M |
| Total Assets | Q3 2025 · Mar 31, 2024 | $27.62M |
| Eps Diluted | Q3 2025 · Dec 31, 2024 | $0.00 |
| Eps Diluted | Q3 2025 · Dec 31, 2024 | $0.00 |
| Eps Diluted | Q3 2025 · Dec 31, 2023 | −$0.05 |
| Eps Diluted | Q3 2025 · Dec 31, 2023 | $0.00 |
| Eps Basic | Q3 2025 · Dec 31, 2024 | $0.00 |
| Eps Basic | Q3 2025 · Dec 31, 2024 | $0.00 |
| Eps Basic | Q3 2025 · Dec 31, 2023 | −$0.05 |
| Eps Basic | Q3 2025 · Dec 31, 2023 | $0.00 |
| Sga Expense | Q3 2025 · Dec 31, 2024 | $1.72M |
| Sga Expense | Q3 2025 · Dec 31, 2024 | $5.2M |
| Sga Expense restated | Q3 2025 · Dec 31, 2023 | $1.51M |
| Sga Expense restated | Q3 2025 · Dec 31, 2023 | $4.9M |
| Rd Expense | Q3 2025 · Dec 31, 2024 | $391K |
| Rd Expense | Q3 2025 · Dec 31, 2024 | $1.25M |
| Rd Expense restated | Q3 2025 · Dec 31, 2023 | $465K |
| Rd Expense restated | Q3 2025 · Dec 31, 2023 | $1.45M |
| Operating Income | Q3 2025 · Dec 31, 2024 | −$410K |
| Operating Income | Q3 2025 · Dec 31, 2024 | −$404K |
| Operating Income restated | Q3 2025 · Dec 31, 2023 | −$97K |
| Operating Income restated | Q3 2025 · Dec 31, 2023 | $685K |
| Gross Profit | Q3 2025 · Dec 31, 2024 | $3.03M |
| Gross Profit | Q3 2025 · Dec 31, 2024 | $9.39M |
| Gross Profit restated | Q3 2025 · Dec 31, 2023 | $3.05M |
| Gross Profit restated | Q3 2025 · Dec 31, 2023 | $10.39M |
| Cost Of Revenue | Q3 2025 · Dec 31, 2024 | $4.21M |
| Cost Of Revenue | Q3 2025 · Dec 31, 2024 | $13.02M |
| Cost Of Revenue restated | Q3 2025 · Dec 31, 2023 | $4.49M |
| Cost Of Revenue restated | Q3 2025 · Dec 31, 2023 | $12.98M |
| Revenue | Q3 2025 · Dec 31, 2024 | $7.24M |
| Revenue | Q3 2025 · Dec 31, 2024 | $22.41M |
| Revenue restated | Q3 2025 · Dec 31, 2023 | $7.54M |
| Revenue restated | Q3 2025 · Dec 31, 2023 | $23.37M |